Head of IR

Attovia Therapeutics, Inc., is seeking a Head of Investor Relations to lead our investor relations function. Reporting to the CFO, the Head of Investor Relations will play a pivotal role in shaping and executing the company's investor relations strategy. This individual will help build and articulate the company's equity narrative to the global investment community — translating complex scientific, clinical, and business information into clear, compelling communications that build trust and credibility with investors and analysts.

Attovia™ is a clinical-stage biopharmaceutical company developing next-generation biotherapeutics for immune-mediated diseases with high unmet need. Our product candidates are internally discovered using our proprietary ATTOBODY™ platform, an evolution-driven, high-throughput biologics platform that enables the rapid discovery and creation of diverse biparatopic complex biologics. Our pipeline spans chronic pruritic diseases, inflammatory skin diseases, inflammatory bowel disease, and other immune-mediated conditions.

Our values define how we make decisions, work with one another, and pursue our mission:

- Integrity: We put patients first, uphold the highest ethical standards, and communicate with honesty and transparency
- Learning & Growth: We ask questions, challenge the status quo, seek and provide constructive feedback, and invest in the development of ourselves and others
- Drive for Excellence: We set ambitious goals, take ownership, honor our commitments, move with urgency, and deliver rigorous, high-quality, and data-driven work
- Innovation: We pursue transformative science, think creatively, and do more with less through resourcefulness and continuous improvement
- Teamwork & Collaboration: We communicate openly, debate constructively, mentor and learn from one another, and recognize that our strongest results come from working together

We take pride in fostering a strong team and dynamic work environment, and we are seeking individuals who align with our values and contribute to a positive and impactful workplace.

Attovia is located in San Carlos, CA.

Attovia is an equal opportunity employer. We consider all qualified applicants for employment without regard to race, color, ancestry, national origin, religion or creed, age, sex, pregnancy, childbirth, breastfeeding or related medical conditions, sexual orientation, gender, gender identity or gender expression, marital status, medical condition, genetic information, physical or mental disability, military or veteran status, reproductive health decision-making, or any other characteristic protected by applicable federal, state, or local law.

Learn more about Attovia: www.attovia.com

Notice to Employment Agencies

The Attovia talent acquisition program is managed through internal resources, and unsolicited referrals and resumes are not accepted from employment agencies, unless advance written authorization is granted from the Human Resources department. Attovia shall not be liable for any fees arising from any unsolicited or unauthorized candidate information received relative to position vacancies.

Responsibilities

Develop and execute a comprehensive investor relations strategy aligned with the company's corporate objectives, pipeline milestones, and long-term growth ambitions; Manage the company’s current investor relations agency and future public relations/media agency; Serve as a day-to-day point of contact for the buy-side and sell-side investment community, fielding inquiries and building relationships with current and prospective shareholders; Partner with agencies to manage the production of investor-facing materials, including all press releases, earnings call scripts and Q&A prep, investor presentations, media communications, fact sheets, and the annual report; Partner with executive team to prepare for and manage quarterly earnings calls, board meetings, investor conferences, medical conferences, non-deal roadshows and R&D-day presentations; Lead proactive and targeted investor outreach, including identifying and cultivating relationships with new institutional investors; Monitor and analyze sell-side analyst research, market activity, shareholder composition, and peer/competitor developments, deliver regular updates and insights to executive team and the Board; Collaborate cross-functionally with R&D, clinical development, regulatory, legal, and corporate communications to ensure accurate, consistent, and compliant messaging across all investor touchpoints; Support corporate development activities, including materials related to M&A, partnerships, licensing deals, and capital markets transactions (e.g., follow-on offerings); Manage corporate website including investor relations section; Ensure compliance with SEC regulations, Regulation FD, and other disclosure requirements in coordination with Legal; Help build out and scale the IR function's tools, processes, and infrastructure as the company grows

Requirements

Bachelor's degree required, MBA, CFA, or advanced scientific degree a plus 8+ years of relevant experience in investor relations, equity research, investment banking, or corporate finance, with a meaningful portion of that experience in biotech, pharma, or life sciences; Experience at a publicly traded biotech/pharmaceutical company strongly preferred, direct experience supporting earnings calls, roadshows, and SEC reporting cycles; Strong understanding of financial reporting, valuation methodologies, and capital markets used by investment professionals; Exceptional written and verbal communication skills, highly organized with meticulous attention to detail and accuracy; Strategic thinker who can manage multiple priorities in a fast-paced, dynamic environment and deliver polished output under tight deadlines

Nice to have

Scientific fluency — comfort engaging with clinical and regulatory content, with the ability to translate complex science into an accessible investment narrative, especially in autoimmune diseases; Experience with IR-specific tools (e.g., shareholder ID/CRM platforms, earnings call/webcast providers) a plus; Proven track record building relationships and influencing across all levels of an organization, including senior executives and the Board